Skip to content
Screener

ADC Therapeutics ADCT Q2 2025 earnings

Reported August 12, 2025 · Before market open

Revenue$18.8MBeat by $645.5K
EPS-$0.50Miss by $0.14
Revenue estimate$18.2M
EPS estimate-$0.36

Next report

Nov 10, 2026 (in 2 months)
Revenue estimate$18.4M
EPS estimate-$0.21

FAQ

When did ADC Therapeutics report Q2 2025 earnings?
ADC Therapeutics (ADCT) reported Q2 2025 earnings on August 12, 2025 before market open.
What were ADC Therapeutics's Q2 2025 revenue and EPS?
ADC Therapeutics reported revenue of $18.8M and eps of $-0.50 for Q2 2025.
Did ADC Therapeutics beat estimates in Q2 2025?
Revenue beat the consensus estimate of $18.2M by $645.5K. EPS missed the consensus estimate of $-0.36 by $0.14.
How did ADC Therapeutics's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 8.2% from $17.4M a year earlier and eps declined 31.6% from $-0.38.
Where can I find ADC Therapeutics's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001771910-25-000006) and the 10-Q periodic report (0001771910-25-000008) directly on SEC EDGAR. The filing index links above go to sec.gov.